Brukinsa Evropska unija - slovenščina - EMA (European Medicines Agency)

brukinsa

beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - antineoplastična sredstva - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).

Jaypirca Evropska unija - slovenščina - EMA (European Medicines Agency)

jaypirca

eli lilly nederland b.v. - pirtobrutinib - limfom, mantle cell - proteinska kinaza inhibitorji - treatment of mantle cell lymphoma (mcl).

Imbruvica Evropska unija - slovenščina - EMA (European Medicines Agency)

imbruvica

janssen-cilag international nv - ibrutinib - lymphoma, mantle-cell; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, protein kinase inhibitors - imbruvica as a single agent is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl). imbruvica as a single agent or in combination with rituximab or obinutuzumab or venetoclax is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. imbruvica as a single agent or in combination with bendamustine and rituximab (br) is indicated for the treatment of adult patients with cll who have received at least one prior therapy. imbruvica as a single agent is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo immunotherapy. imbruvica in combination with rituximab is indicated for the treatment of adult patients with wm.

Rutacid 500 mg žvečljive tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

rutacid 500 mg žvečljive tablete

krka, d.d., novo mesto - hidrotalcit - žvečljiva tableta - hidrotalcit 500 mg / 1 tableta - hidrotalcit

Rutacid 500 mg žvečljive tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

rutacid 500 mg žvečljive tablete

krka, d.d., novo mesto - hidrotalcit - žvečljiva tableta - hidrotalcit 500 mg / 1 tableta - hidrotalcit